Learn more about Arovella Therapeutics and our Licence Agreement with Imperial College London, providing us with the exclusive, global rights to commercialise its invariant Natural Killer T (iNKT) Cell Therapy Platform for the treatment of human disease.
#CellTherapy #ASX #NaturalKiller #HumanDisease #CancerTreatment
Disclaimer:
If you own the YouTube channel related to this video and do not want it to be featured here, you can contact us through our contact page. We will gladly remove it without questioning your reason